相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Decisions About Dendritic Cells: Past, Present, and Future
Ralph M. Steinman
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN
Luis J. Cruz et al.
BIOMATERIALS (2012)
The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells
Gerty Schreibelt et al.
BLOOD (2012)
Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma
Trine O. Jensen et al.
CANCER (2012)
Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria
Marzia Palma et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients
Osama E. Rahma et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission
Christina S. Chu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer
Chun-Jian Qi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial
Eva Ellebaek et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Harnessing human plasmacytoid dendritic cells as professional APCs
Jurjen Tel et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Exploiting the Mutanome for Tumor Vaccination
John C. Castle et al.
CANCER RESEARCH (2012)
Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor
Xun Xu et al.
CELL (2012)
Clinical Application of a Dendritic Cell Vaccine Raised Against Heat-Shocked Glioblastoma
X. Jie et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2012)
A phase I pilot trial of MUC1-peptide-pulsed dendritic cells in the treatment of advanced pancreatic cancer
Yefei Rong et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2012)
Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
Yu Sawada et al.
CLINICAL CANCER RESEARCH (2012)
Antibodies and carbohydrate ligands binding to DC-SIGN differentially modulate receptor trafficking
Paul J. Tacken et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
COMBINATION OF EXTERNAL BEAM RADIOTHERAPY (EBRT) WITH INTRATUMORAL INJECTION OF DENDRITIC CELLS AS NEO-ADJUVANT TREATMENT OF HIGH-RISK SOFT TISSUE SARCOMA PATIENTS
Steven E. Finkelstein et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8+ T cells and activating Foxp3+ regulatory T cells
Mercedes Gomez de Agueero et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells
Dapeng Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma
Koichi Shimizu et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2012)
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma
Jose Pulido et al.
NATURE BIOTECHNOLOGY (2012)
The secret ally: immunostimulation by anticancer drugs
Lorenzo Galluzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Dendritic/Tumor Fusion Cells as Cancer Vaccines
David Avigan et al.
SEMINARS IN ONCOLOGY (2012)
Trial Watch Adoptive cell transfer immunotherapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
Trial watch Monoclonal antibodies in cancer therapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
Trial Watch Immunostimulatory cytokines
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Trial Watch Experimental Toll-like receptor agonists for cancer therapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
Trial watch Chemotherapy with immunogenic cell death inducers
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Trial watch FDA-approved Toll-like receptor agonists for cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma
Jacalyn Rosenblatt et al.
BLOOD (2011)
Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation
Paul J. Tacken et al.
BLOOD (2011)
Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity
Paul J. Tacken et al.
BLOOD (2011)
Tumor microenvironment is multifaceted
Catherine Sautes-Fridman et al.
CANCER AND METASTASIS REVIEWS (2011)
Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide
Mitsuru Sakakibara et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study
Christian Bauer et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
Else M. Inderberg Suso et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer
Sylvain Ladoire et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Peptide-Loaded Langerhans Cells, Despite Increased IL15 Secretion and T-Cell Activation In Vitro, Elicit Antitumor T-Cell Responses Comparable to Peptide-Loaded Monocyte-Derived Dendritic Cells In Vivo
Emanuela Romano et al.
CLINICAL CANCER RESEARCH (2011)
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2011)
Dendritic cell-tumor cell hybrids and immunotherapy: what's next?
Dominique Cathelin et al.
CYTOTHERAPY (2011)
Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma
J. C. Steele et al.
GENE THERAPY (2011)
Natural killer (NK):dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity
Steve C. Lee et al.
IMMUNOLOGIC RESEARCH (2011)
Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study
Mauricio W. Perroud et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Antibody-Targeted NY-ESO-1 to Mannose Receptor or DEC-205 In Vitro Elicits Dual Human CD8+ and CD4+ T Cell Responses with Broad Antigen Specificity
Takemasa Tsuji et al.
JOURNAL OF IMMUNOLOGY (2011)
Recent Developments in Cancer Vaccines
Karolina Palucka et al.
JOURNAL OF IMMUNOLOGY (2011)
Pilot Clinical Trial of Type 1 Dendritic Cells Loaded with Autologous Tumor Lysates Combined with GM-CSF, Pegylated IFN, and Cyclophosphamide for Metastatic Cancer Patients
Carlos Alfaro et al.
JOURNAL OF IMMUNOLOGY (2011)
Induction of Cellular Immune Responses in Patients With Stage-I Multiple Myeloma After Vaccination With Autologous Idiotype-pulsed Dendritic Cells
Christoph Roellig et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
Camilo E. Fadul et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Updated Technology to Produce Highly Immunogenic Dendritic Cell-derived Exosomes of Clinical Grade: A Critical Role of Interferon-gamma
Sophie Viaud et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial
Soyoung Baek et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses
I. Jolanda M. de Vries et al.
MOLECULAR IMMUNOLOGY (2011)
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
Nicolas F. Delahaye et al.
NATURE MEDICINE (2011)
IRF8 Mutations and Human Dendritic-Cell Immunodeficiency
Sophie Hambleton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Mickael Michaud et al.
SCIENCE (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA-Peptide Complexes in Systemic Lupus Erythematosus
Roberto Lande et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus
Gina S. Garcia-Romo et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Harnessing dendritic cells in cancer
Lionel Apetoh et al.
SEMINARS IN IMMUNOLOGY (2011)
Early Experience with Targeted Therapy and Dendritic Cell Vaccine in Metastatic Renal Cell Carcinoma after Nephrectomy
Marcos F. Dall'Oglio et al.
INTERNATIONAL BRAZ J UROL (2011)
Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system?
Boris Reizis et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Consolidative Dendritic Cell-based Immunotherapy Elicits Cytotoxicity against Malignant Mesothelioma
Joost P. Hegmans et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells
Gerty Schreibelt et al.
BLOOD (2010)
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
Eynav Klechevsky et al.
BLOOD (2010)
Dendritic Cells Are They Clinically Relevant?
Karolina Palucka et al.
CANCER JOURNAL (2010)
Dendritic Cell-Derived Exosomes for Cancer Immunotherapy: What's Next?
Sophie Viaud et al.
CANCER RESEARCH (2010)
Improved Clinical Outcome in Indolent B-Cell Lymphoma Patients Vaccinated with Autologous Tumor Cells Experiencing Immunogenic Death
Roberta Zappasodi et al.
CANCER RESEARCH (2010)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
A Randomized Trial of Ex vivo CD40L Activation of a Dendritic Cell Vaccine in Colorectal Cancer Patients: Tumor-Specific Immune Responses Are Associated with Improved Survival
Richard J. Barth et al.
CLINICAL CANCER RESEARCH (2010)
Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
Redas Trepiakas et al.
CYTOTHERAPY (2010)
INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect
Alberto A. Chiappori et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Regulation of dendritic cell differentiation and function by Notch and Wnt pathways
Pingyan Cheng et al.
IMMUNOLOGICAL REVIEWS (2010)
Harnessing human dendritic cell subsets for medicine
Hideki Ueno et al.
IMMUNOLOGICAL REVIEWS (2010)
Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance
Melissa Swiecki et al.
IMMUNOLOGICAL REVIEWS (2010)
Mycobacterium tuberculosis impairs dendritic cell response by altering CD1b, DC-SIGN and MR profile
Luciana Balboa et al.
IMMUNOLOGY AND CELL BIOLOGY (2010)
The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8α+ dendritic cells
Karine Crozat et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
Sarah L. Jongbloed et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells
Annabell Bachem et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells
Lionel Franz Poulin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Dendritic Cells Induce Regulatory T Cell Proliferation through Antigen-Dependent and -Independent Interactions
Tao Zou et al.
JOURNAL OF IMMUNOLOGY (2010)
Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy
Pierpaolo Correale et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Generation of Tumor-specific T Lymphocytes Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28
Jacalyn Rosenblatt et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
Hilko Ardon et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Improved Endpoints for Cancer Immunotherapy Trials
Axel Hoos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
Antoni Ribas et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Phase I study of autologous dendritic cell tumor vaccine in patients with non-small cell lung cancer
Soo-Jung Um et al.
LUNG CANCER (2010)
Sipuleucel-T
Celestia S. Higano et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Harnessing Naturally Occurring Tumor Immunity: A Clinical Vaccine Trial in Prostate Cancer
Mayu O. Frank et al.
PLOS ONE (2010)
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
Viggo F. Van Tendeloo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses
Marij J. P. Welters et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Changes in cytokine and biomarker blood levels in patients with colorectal cancer during dendritic cell-based vaccination
Stefan K. Burgdorf et al.
ACTA ONCOLOGICA (2009)
Idiotype-pulsed antigen presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival
Martha Q. Lacy et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Combining Conventional Therapies with Intratumoral Injection of Autologous Dendritic Cells and Activated T Cells to Treat Patients with Advanced Cancers
Dean L. Mann et al.
CANCER VACCINES (2009)
Vaccines for lymphomas: Idiotype vaccines and beyond
Roch Houot et al.
BLOOD REVIEWS (2009)
Integrated Data From 2 Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials of Active Cellular Immunotherapy With Sipuleucel-T in Advanced Prostate Cancer
Celestia S. Higano et al.
CANCER (2009)
Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report
Robert O. Dillman et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responses
Jun Zhou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma
Antoni Ribas et al.
CLINICAL CANCER RESEARCH (2009)
Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients
Han Chong Toh et al.
CLINICAL CANCER RESEARCH (2009)
Clinical and Immunologic Effects of Intranodal Autologous Tumor Lysate-Dendritic Cell Vaccine with Aldesleukin (Interleukin 2) and IFN-α2a Therapy in Metastatic Renal Cell Carcinoma Patients
Thomas Schwaab et al.
CLINICAL CANCER RESEARCH (2009)
Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial
Ann Van Driessche et al.
CYTOTHERAPY (2009)
RNA-based immunotherapy of cancer: role and therapeutic implications of dendritic cells
Rajeev K. Tyagi et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
A Phase II Study of Adoptive Immunotherapy Using Dendritic Cells Pulsed with Tumor Lysate in Patients with Hepatocellular Carcinoma
Daniel H. Palmer et al.
HEPATOLOGY (2009)
Prolonged Survival of Dendritic Cell-Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor β-Expressing T Cells
Mercedes N. Lopez et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
CD2 Distinguishes Two Subsets of Human Plasmacytoid Dendritic Cells with Distinct Phenotype and Functions
Toshimichi Matsui et al.
JOURNAL OF IMMUNOLOGY (2009)
An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
John H. Sampson et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Magnetic Resonance Imaging-Guided Adoptive Cellular Immunotherapy of Central Nervous System Tumors With a T-1 Contrast Agent
Raghvendra S. Sengar et al.
MAGNETIC RESONANCE IN MEDICINE (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma
Thomas Bachleitner-Hofmann et al.
ONCOLOGY REPORTS (2009)
Immune Responses in Patients with Metastatic Renal Cell Carcinoma Treated with Dendritic Cells Pulsed with Tumor Lysate
A. Soleimani et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
Immunogenic and tolerogenic cell death
Douglas R. Green et al.
NATURE REVIEWS IMMUNOLOGY (2009)
The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement
Irina Caminschi et al.
BLOOD (2008)
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme
Steven De Vleeschouwer et al.
CLINICAL CANCER RESEARCH (2008)
Oxidation of ovarian epithelial cancer cells by hypochlorous acid enhances immunogenicity and stimulates T cells that recognize autologous primary tumor
Cheryl L-L. Chiang et al.
CLINICAL CANCER RESEARCH (2008)
Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies
Consuelo M. Lopez de Padilla et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
Paradigm shifts in cancer vaccine therapy
Jeffrey Schlom et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
Production of IL12p70 and IL23 by monocyte-derived dendritic cells in children with inflammatory bowel disease
G. M. Damen et al.
GUT (2008)
Functional specializations of human epidermal langerhans cells and CD14+ dermal dendritic cells
Eynav Klechevsky et al.
IMMUNITY (2008)
Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures
Marie-Caroline Dieu-Nosjean et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Fungal proteases induce Th2 polarization through limited dendritic cell maturation and reduced production of IL-12
Salah-Eddine Lamhamedi-Cherradi et al.
JOURNAL OF IMMUNOLOGY (2008)
Vaccination of a melanoma patient with mature dendritic cells pulsed with MAGE-3 peptides triggers the activity of nonvaccine anti-tumor cells
Javier Carrasco et al.
JOURNAL OF IMMUNOLOGY (2008)
Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells
Baldev Vasir et al.
JOURNAL OF IMMUNOLOGY (2008)
Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients
Nadege Bercovici et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma - A clinical, phase 1/2 trial
Annika Berntsen et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma
Bruce G. Redman et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Interferon-alpha (IFN-α)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients
Margherita Gigante et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy
Paul Hatfield et al.
JOURNAL OF IMMUNOTHERAPY (2008)
A phase 1 clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells.: Analysis of toxicity and immune response to the vaccine and of IL-10-1082 promoter genotype as predictor of disease progression
Erika M. von Euw et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response
I. Hus et al.
LEUKEMIA (2008)
Molecular origins of cancer - Cancer immunology
Olivera J. Finn
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2
Inge Marie Svane et al.
VACCINE (2008)
Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma
P. Hersey et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: A phase I escalating-dose trial
Alessandro D. Santin et al.
JOURNAL OF VIROLOGY (2008)
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas
Hideho Okada et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production
Stephen N. Waggoner et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors
Ayala Tamir et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Taming cancer by inducing immunity via dendritic cells
A. Karolina Palucka et al.
IMMUNOLOGICAL REVIEWS (2007)
Skin biopsies in DC vaccines for stage III-IV melanoma patients: Role of neutrophils?
M. Laporte et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2007)
Distribution patterns of dendritic cells and T cells in Diffuse large B-cell lymphomas correlate with prognoses
Kung-Chao Chang et al.
CLINICAL CANCER RESEARCH (2007)
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides
Antonio Curti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Dendritic cell subsets in health and disease
Hideki Ueno et al.
IMMUNOLOGICAL REVIEWS (2007)
Dendritic-cell immunotherapy:: from ex vivo loading to in vivo targeting
Paul J. Tacken et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides
Brian Kavanagh et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Taking dendritic cells into medicine
Ralph M. Steinman et al.
NATURE (2007)
Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system
Pedro Berraondo et al.
CANCER RESEARCH (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Density of DC-LAMP+ mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor
Andrea Ladanyi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Immunization of NSCLC patients with antigen-pulsed immature autologous dendritic cells
Edward A. Hirschowitz et al.
LUNG CANCER (2007)
Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers
Inge Marie Svane et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
B subunit of Shiga toxin-based Vaccines synergize with α-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity
Olivier Adotevi et al.
JOURNAL OF IMMUNOLOGY (2007)
Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma - Evidence of systemic immune dysfunction
Esteban Celis
CANCER (2007)
Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma
Jun Guo et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development
Caroline Aspord et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity
Peter B. Stranges et al.
IMMUNITY (2007)
DC-based cancer vaccines
Eli Gilboa
JOURNAL OF CLINICAL INVESTIGATION (2007)
Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells -: A pilot study
B. Hildenbrand et al.
PROSTATE (2007)
Immunotherapy against metastatic renal cell carcinoma with mature dendritic cells
Akihiko Matsumoto et al.
INTERNATIONAL JOURNAL OF UROLOGY (2007)
Unique human tumor antigens: Immunobiology and use in clinical trials
Giorgio Parmiani et al.
JOURNAL OF IMMUNOLOGY (2007)
Differential antigen processing by dendritic cell subsets in vivo
Diana Dudziak et al.
SCIENCE (2007)
Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells
Ivar Bleumer et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Mitochondrial membrane permeabilization in cell death
Guido Kroemer et al.
PHYSIOLOGICAL REVIEWS (2007)
Phase I study of tumor Ag-loaded IL-12 secreting semi-mature DC for the treatment of pediatric cancer
A. M. Dohnal et al.
CYTOTHERAPY (2007)
Results of a phase I clinical study using dendritic cell vaccinations for thyroid cancer
Koichiro Kuwabara et al.
THYROID (2007)
Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients
Thierry Lesimple et al.
CLINICAL CANCER RESEARCH (2006)
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Ying Waeckerle-Men et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival
Anna-K. Thomas-Kaskell et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Exosomes: From biogenesis and secretion to biological function
Sascha Keller et al.
IMMUNOLOGY LETTERS (2006)
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells
Jon A. Kyte et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Interleukin-23 drives innate and T cell-mediated intestinal inflammation
Sophie Hue et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
J. A. Kyte et al.
CANCER GENE THERAPY (2006)
Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34+ progenitor-derived dendritic cells
Joseph W. Fay et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146-154 peptide
Supriya Perambakam et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells
Jinwei Hu et al.
CANCER RESEARCH (2006)
A biophysical approach to the optimisation of dendritic-tumour cell electrofusion
Vladimir L. Sukhorukov et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinoma
Claudia Papewalis et al.
CLINICAL ENDOCRINOLOGY (2006)
Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection
Shabaana A. Khader et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
Eric J. Small et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
M Salcedo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Vaccination of Japanese patients with advanced melanoma with peptide, tumor lysate or both peptide and tumor lysate-pulsed mature, monocyte-derived dendritic cells
Noriaki Nakai et al.
JOURNAL OF DERMATOLOGY (2006)
Cutting edge:: Dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice
Cheng-Hu Liu et al.
JOURNAL OF IMMUNOLOGY (2006)
Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients
Jan Wierecky et al.
CANCER RESEARCH (2006)
Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells:: Results of a Phase I clinical trial
Susanne Fuessel et al.
PROSTATE (2006)
The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity
Benoit Vingert et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Measuring response in a post-RECIST world: from black and white to shades of grey
LC Michaelis et al.
NATURE REVIEWS CANCER (2006)
Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-α results in the activation of specific CD8+ T cells and monocyte/dendritic cell precursors
Tiziana Di Pucchio et al.
CANCER RESEARCH (2006)
In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses
SH Kassim et al.
JOURNAL OF VIROLOGY (2006)
Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses
S Homma et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells
J Babatz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Mannan-MUC1 - Pulsed dendritic cell immunotherapy: A phase I trial in patients with adenocarcinoma
BE Loveland et al.
CLINICAL CANCER RESEARCH (2006)
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
SJ Antonia et al.
CLINICAL CANCER RESEARCH (2006)
Dendritic cell derived-exosomes: biology and clinical implementations
Nathalie Chaput et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation
M Bendandi et al.
LEUKEMIA & LYMPHOMA (2006)
Dendritic cell-based cancer immunotherapy targeting MUC-1
J Wierecky et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming
F Errington et al.
GENE THERAPY (2006)
Essay - Dendritic cells in a mature age
Caetano Reis e Sousa
NATURE REVIEWS IMMUNOLOGY (2006)
Type I interferon in systemic lupus erythematosus and other autoimmune diseases
Jacques Banchereau et al.
IMMUNITY (2006)
Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
MA Lowes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
N Casares et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma
RB Batchu et al.
CANCER RESEARCH (2005)
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
IJM de Vries et al.
NATURE BIOTECHNOLOGY (2005)
CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner
F Ghiringhelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients
LJ Mu et al.
BRITISH JOURNAL OF CANCER (2005)
Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon
J Banchereau et al.
JOURNAL OF IMMUNOTHERAPY (2005)
In vivo depletion of CD11c+ cells delays the CD4+ T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection
T Tian et al.
JOURNAL OF IMMUNOLOGY (2005)
Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia
I Hus et al.
LEUKEMIA (2005)
Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome
IJM de Vries et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody
PJ Tacken et al.
BLOOD (2005)
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
G Napolitani et al.
NATURE IMMUNOLOGY (2005)
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
LM Liau et al.
CLINICAL CANCER RESEARCH (2005)
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
FO Nestle et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide
L Höltl et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: Results of a clinical phase I/II trial
R Yamanaka et al.
CLINICAL CANCER RESEARCH (2005)
Fusion hybrids of dendritic cells and autologous myeloid blasts as a potential cellular vaccine for acute myeloid leukaemia
M Klammer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: Role of maturation status and intratumoral localization
MH Sandel et al.
CLINICAL CANCER RESEARCH (2005)
Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells
HC Probst et al.
JOURNAL OF IMMUNOLOGY (2005)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Cancer immunotherapy by fusions of dendritic and tumour cells and rh-IL-12
S Homma et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2005)
Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results
U Trefzer et al.
VACCINE (2005)
Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer
Z Su et al.
JOURNAL OF IMMUNOLOGY (2005)
Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with stage 4 neuroblastoma
DA Caruso et al.
CANCER (2005)
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes:: results of thefirst phase I clinical trial
B Escudier et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Increased blood myeloid dendritic cells and dendritic cell-poietins in Langerhans cell histiocytosis
A Rolland et al.
JOURNAL OF IMMUNOLOGY (2005)
Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4
HC Probst et al.
NATURE IMMUNOLOGY (2005)
Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma
KW Chi et al.
JOURNAL OF IMMUNOTHERAPY (2005)
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
MA Morse et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Cell biology of antigen processing in vitro and in vivo
ES Trombetta et al.
ANNUAL REVIEW OF IMMUNOLOGY (2005)
Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells - A clinical trial
WC Lee et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Dendritic cell immunotherapy: mapping the way
CG Figdor et al.
NATURE MEDICINE (2004)
Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity
SC Yang et al.
CLINICAL CANCER RESEARCH (2004)
In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination
LC Bonifaz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Antitumor effects of vaccine consisting of dendritic cells pulsed with tumor RNA from gastric cancer
Bing-Ya Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
Induction of cytotoxic T lymphocytes by dendritic cells pulsed with murine leukemic cell RNA
CW Jung et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
Hybrid cell vaccination in metastatic melanoma - Clinical and immunologic results of a phase I/II study
HA Haenssle et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Exosomes as potent cell-free peptide-based vaccine.: I.: Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells
F André et al.
JOURNAL OF IMMUNOLOGY (2004)
Exosomes as potent cell-free peptide-based vaccine.: II.: Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection
N Chaput et al.
JOURNAL OF IMMUNOLOGY (2004)
Vaccination of cancer patients against telomerase induces functional antitumor CD8+T lymphocytes
RH Vonderheide et al.
CLINICAL CANCER RESEARCH (2004)
Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma
P Hersey et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Dendritic cell-tumor fusion vaccines for renal cell carcinoma
D Avigan
CLINICAL CANCER RESEARCH (2004)
Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy
A Ribas et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer
EC Dees et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells
TG Berger et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34+-derived dendritic cell vaccination:: A phase I trial in metastatic melanoma
M Di Nicola et al.
CLINICAL CANCER RESEARCH (2004)
Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II study
HS Pandha et al.
BJU INTERNATIONAL (2004)
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
JS Yu et al.
CANCER RESEARCH (2004)
Autologous dendritic cell vaccines for non-small-cell lung cancer
EA Hirschowitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses
D Avigan et al.
CLINICAL CANCER RESEARCH (2004)
Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T-cell and clinical responses in melanoma stage III and IV patients
U Trefzer et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Cancer immunotherapy: A treatment for the masses
JN Blattman et al.
SCIENCE (2004)
Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate
R Vilella et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study
IM Svane et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Dendritic cell-tumor cell hybrid vaccination for metastatic cancer
JAM Barbuto et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide-pulsed dendritic cells
K Matsuda et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer
DA Caruso et al.
NEURO-ONCOLOGY (2004)
The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation
SI Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells
S Paczesny et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLL
P Kokhaei et al.
LEUKEMIA (2004)
Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12
T Kikuchi et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma
N Raje et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA
B Barrou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients
I Bedrosian et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
R Yamanaka et al.
BRITISH JOURNAL OF CANCER (2003)
Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2
H Nagayama et al.
MELANOMA RESEARCH (2003)
Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells
T Maier et al.
BLOOD (2003)
Electrofusion of syngeneic dendritic cells and tumor generates potent therapeutic vaccine
J Kjaergaard et al.
CELLULAR IMMUNOLOGY (2003)
Tumor mRNA-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma
T Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Herpes simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic cells in vitro
CA Jones et al.
JOURNAL OF VIROLOGY (2003)
Dendritic cell vaccination for patients with chronic myelogenous leukemia
T Takahashi et al.
LEUKEMIA RESEARCH (2003)
Enhancement of antigen-presenting capacity and antitumor immunity of dendritic cells pulsed with autologous tumor-derived RNA in mice
T Minami et al.
JOURNAL OF IMMUNOTHERAPY (2003)
A pilot trial of tumor lysate-loaded dendritic cells for the treatment of metastatic renal cell carcinoma
BJ Gitlitz et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Dendritic cell-based tumor vaccine for cervical cancer II:: results of a clinical pilot study in 15 individual patients
A Ferrara et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2003)
Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6
G Jego et al.
IMMUNITY (2003)
Antigen presentation to naive CD4 T cells in the lymph node
AA Itano et al.
NATURE IMMUNOLOGY (2003)
Cancer vaccines: Between the idea and the reality
OJ Finn
NATURE REVIEWS IMMUNOLOGY (2003)
Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma
AC Peterson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Generation of cytotoxic responses in mice and human individuals against hematological malignancies using survivin-RNA-transfected dendritic cells
M Zeis et al.
JOURNAL OF IMMUNOLOGY (2003)
Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell-tumour hybrids in B-CLL
P Kokhaei et al.
LEUKEMIA (2003)
Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas
M Iwamoto et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Allogeneic dendritic cells fused with tumor cells:: Preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma
A Märten et al.
HUMAN GENE THERAPY (2003)
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells
CL Slingluff et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA
MA Morse et al.
CANCER INVESTIGATION (2003)
Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance
L Bonifaz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Mucin gene (MUC1) transfected dendritic cells as vaccine:: results of a phase I/II clinical trial
G Pecher et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells:: preclinical results and outcome of a first clinical phase I/II trial
A Märten et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Natural type I interferon-producing cells as a link between innate and adaptive immunity
N Kadowaki et al.
HUMAN IMMUNOLOGY (2002)
Therapeutic immune response induced by electrofusion of dendritic and tumor cells
H Tanaka et al.
CELLULAR IMMUNOLOGY (2002)
Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells
OMZ Howard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Efficient genetic modification of murine dendritic cells by electroporation with mRNA
S Van Meirvenne et al.
CANCER GENE THERAPY (2002)
The treatment of patients with disseminated malignant melanoma by vaccination with autologous cell hybrids of tumor cells and dendritic cells
SW Krause et al.
JOURNAL OF IMMUNOTHERAPY (2002)
γ-secretase-mediated proteolysis in cell-surface-receptor signalling
ME Fortini
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod
SJ Gibson et al.
CELLULAR IMMUNOLOGY (2002)
The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor
M Gilliet et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Interferon α/β and interleukin 12 responses to viral infections:: Pathways regulating dendritic cell cytokine expression in vivo
M Dalod et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Tumour escape from immune surveillance through dendritic cell inactivation
AP Vicari et al.
SEMINARS IN CANCER BIOLOGY (2002)
Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: An inter-institute NIH study
R Dagher et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2002)
Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial
JJ Hernando et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy
L Fong et al.
JOURNAL OF IMMUNOLOGY (2001)
Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus
P Blanco et al.
SCIENCE (2001)
Mature dendritic cells infiltrate the T cell-rich region of oral mucosa in chronic periodontitis: In situ, in vivo, and in vitro studies
R Jotwani et al.
JOURNAL OF IMMUNOLOGY (2001)
Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumor vaccine
RJ Orentas et al.
CELLULAR IMMUNOLOGY (2001)
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo
D Hawiger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens
N Kadowaki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells
Z Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Dendritic cells as vectors for therapy
J Banchereau et al.
CELL (2001)
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
L Fong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Dendritic cells injected via different routes induce immunity in cancer patients
L Fong et al.
JOURNAL OF IMMUNOLOGY (2001)
Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki Forest virus-mediated complementary DNA
R Yamanaka et al.
JOURNAL OF NEUROSURGERY (2001)
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
J Wolfers et al.
NATURE MEDICINE (2001)
Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells
F Berard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Efficient nonviral transfection of dendritic cells and their use for in vivo immunization
AS Irvine et al.
NATURE BIOTECHNOLOGY (2000)
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
P Chomarat et al.
NATURE IMMUNOLOGY (2000)
Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA
S Koido et al.
JOURNAL OF IMMUNOLOGY (2000)
Clinical trials of immunotherapy for advanced prostate cancer
K Kuratsukuri et al.
UROLOGIC ONCOLOGY (2000)
Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer
S Ishigami et al.
CANCER LETTERS (2000)
Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent THI polarization
M Cella et al.
NATURE IMMUNOLOGY (2000)
Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses
M Nouri-Shirazi et al.
JOURNAL OF IMMUNOLOGY (2000)
Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100
MC Panelli et al.
JOURNAL OF IMMUNOTHERAPY (2000)
Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines
C Klein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
TBH Geijtenbeek et al.
CELL (2000)
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
SK Nair et al.
NATURE MEDICINE (2000)
Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects
S Titzer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells
A Ribas et al.
JOURNAL OF IMMUNOTHERAPY (2000)
分享论文
